Phase II study of pre and post operative combination chemotherapy using carboplatin and dose dense paclitaxel (dose dense TC therapy) for locally advanced cervical cancer
Phase 2
- Conditions
- FIGO stage Ib2, IIa2, or IIb cervical cancer
- Registration Number
- JPRN-UMIN000015184
- Lead Sponsor
- Sankai Gynecology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Prior chemotherapy nor radiation therapy for cervical cancer. 2. Simultaneous active cancer. 3. Serious coexisting illness 4. Carrier of viral hepatitis 5. Active infection 6. Interstitial pneumonia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 year recurrence free survival
- Secondary Outcome Measures
Name Time Method objective response rate, pathological response rate, 2 year overall survival, toxicity, site of recurrence, completion rate of protocol therapy